Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
APR Applied Pharma Research is a Swiss-based biopharmaceutical company, now a subsidiary of Relief Therapeutics, specializing in the development of innovative drug delivery systems and products for rare diseases and niche conditions. The company is best known for its Physiomimic Technology, which is used to create Golike, a specialized medical food for the management of Phenylketonuria (PKU). APR also maintains a portfolio in cancer supportive care and wound management, utilizing proprietary delivery platforms to improve the efficacy and patient compliance of established compounds. Their business model combines internal R&D with strategic licensing partnerships to commercialize products globally. The company's Tehclo platform is another key asset, producing high-purity hypochlorous acid solutions for wound care and anti-infective applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on APR Italy.